Psychosis, Mood and Behavioral Disorders in Usher Syndrome: Review of the Literature by Domanico, Daniela et al.
 
 
Med Hypothesis Discov Innov Ophthalmol. 2015; 4(2)  
 
 
 
Review 
Medical Hypothesis, Discovery &Innovation  
Ophthalmology Journal 
   
 
 
Psychosis, Mood and Behavioral Disorders in Usher Syndrome: 
Review of the Literature 
 
Daniela Domanico, Serena Fragiotta, Alessandro Cutini, Pier Luigi Grenga, Enzo Maria Vingolo  
Department of Medical–Surgical Sciences and Biotechnologies, U.O.S.D. Ophthalmology, Sapienza University of Rome, Terracina, Italy 
ABSTRACT 
The aim of this review is to focus the current knowledge about mental and behavioral disorders in Usher 
syndrome. Previous studies described the presence of various mental disorders associated with Usher 
syndrome, suggesting possible mechanisms of association between these disorders. The most common 
manifestations are schizophrenia-like disorder and psychotic symptoms. Mood and behavioral disorders 
are rarely described, and often are associated with more complex cases in co-occurrence with other 
psychiatric disorders. Neuroimaging studies reported diffuse involvement of central nervous system (CNS) 
in Usher patients, suggesting a possible role of CNS damage in the pathogenesis of psychiatric 
manifestations. Genetic hypothesis and stress-related theories have also been proposed. 
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INTRODUCTION 
Usher syndrome (USH) is characterized by congenital 
sensorineural hearing loss, retinitis pigmentosa (RP), and 
sometimes, vestibular areflexia (1). The prevalence rate 
of USH is about 5–6 per 100,000 in northern Europe 
population and in the USA, and it represents the major 
cause of genetic deafness and blindness (1–4). Three 
clinical subtypes are distinguished on the basis of the 
severity of hearing loss, vestibular dysfunction and the 
age of onset of RP. Type I (USH1) is characterized by 
profound congenital deafness, prepubertal-onset RP, 
vestibular dysfunction. Usher syndrome type II (USH2) is 
characterized by congenital mild to severe hearing loss, 
adolescent-onset RP and no vestibular dysfunction. 
Usher syndrome type III (USH3) is characterized by 
rapidly progressive hearing loss. Age of onset of RP and 
the degree of vestibular dysfunction are variable (5–6). 
Previous studies reported the presence of various mental 
disorders associated with Usher syndrome, suggesting 
mechanism of association between Usher syndrome and 
mental and behavioral disorder (7–9). Despite these 
findings, to date the literature offers fragmented 
information, mostly case reports, and few observational 
obsolete studies. In addition, there are no revisions that 
could help to focus the current knowledge about this 
association. This article reviews the current literature 
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about the relationship of mental and behavioral 
disorders and Usher syndrome. The aims of this review 
include i) to report the prevalence and which type of 
disorders have been found in USH patients, ii) 
neuroradiological, clinical and molecular aspects that 
may predispose to mental and behavioral disorders and 
iii) current theories and the new hypotheses about 
relationships between these disorders and USH. 
 
Epidemiology  
There are conflicting data about the prevalence of 
psychotic disorders in USH patients. Hallgren (7) reported 
that psychosis was diagnosed in 26 of 114 persons (23% 
of cases) with Usher syndrome in a Swedish cohort. 
Nuutila (8) observed the prevalence of psychosis in 6 of 
131 patients (4.5% of cases). He suggested that the data 
about psychosis prevalence in the Hallgren’s study was 
overestimate. Dammeyer (9) and Grøndahl and Mjøen 
(10) have confirmed these data, reporting schizophrenia 
in 1 of 26 patients (3.84%) and in 1 of 27 patients 
(3.70%), respectively. In addition, Dammeyer (9) 
reported that 23% of USH patients manifested mental or 
behavioral disorders, included schizophrenia, mild and 
severe mental retardation, atypical autism, and conduct 
disorder. The prevalence for schizophrenia is 
approximately 1.1% of the US population, (11) thus the 
prevalence of schizophrenia in Usher population is 
greater than US population. Nevertheless, the estimation 
of mental disability or psychosis in USH patients is 
difficult due to communication barriers. 
 
Usher Syndrome AND CNS Abnormalities (Figure 1) 
Computed tomographic (CT) and magnetic resonance 
imaging (MRI) studies have shown various abnormalities 
of CNS. Cerebellar and cerebral atrophy, focal lesions, 
hypoplasia of corpus callosum and dilatation of fourth 
ventricle, decrease in intracranial volume with an 
increase in the size of the subarachnoid spaces, and 
arachnoid cyst together with cavum septi pellucidi et 
vergae. (12–16) The increase in the subarachnoid spaces 
seems to be related to the decrease in the total 
intracranial volume. These abnormalities are reported 
both in Usher type I and II, but USH type I patients are 
more severely affected with more prominent atrophy 
and cerebellar involvement (14). Tamayo et al. reported 
that 18 of 30 patients (60%) presented cerebellar 
abnormality at MRI of the brain. 
The most common abnormal pattern (14 of 30 patients) 
was atrophy involving mainly the vermis. Although 
abnormal gait was very common in both USH type I 
(88.9%) and Type II (66.7%) patients, no correlation 
between cerebellar and gait abnormalities was found. 
According to the authors the pathogenesis of gait seems 
to be related to the loss of vestibular function in USH I 
and to cerebellar structural abnormalities in USH II (16). 
Positron emission tomography (PET) revealed a 
generalised reduction of cerebral blood flow and cerebral 
oxygen consumption in the cerebral cortex and 
subcortex, especially in the pallidum, but with relatively 
preservation of the basal ganglia (12).  
Psychotic Disorders  
The association between Usher syndrome and psychiatric 
disorders is already known by many years. The most 
common manifestation reported is schizophrenia-like 
psychosis. (17–24) 
There are a limited number of reports that offer a 
description about psychotic features of USH patients. 
Nevertheless, often the descriptions of auditory and 
visual hallucinations are only presumptive and based on 
the behavior of the subjects, due to poor communication 
skills of the patients. Sometimes the diagnosis of 
schizophrenia cannot be established with certainty; as 
well as psychometric evaluation cannot be performed in 
most cases. Table 1 reported case studies found in the 
literature regarding the association between Usher 
syndrome and psychiatric manifestations. We 
summarized the main mental and behavioral symptoms 
and the mental status. 
In two case reports, the authors described the cases of 
two siblings with USH and psychotic symptoms (22,24). 
Furthermore, a positive family history of schizophrenia 
was reported in other two case reports (18,20). In most 
cases described, the authors reported a clinical picture 
resembling paranoid schizophrenia, none of these cases 
presented with catatonic symptoms. 
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Figure 1. Summarized Neuroimaging Findings in USH Patients 
 
 
Persecutory delusion was the most common form of 
delusions reported. In two cases were described religious 
delusions (17,19). The behavior was aggressive in the 
majority of cases. Moreover, patients were often 
severely anxious and irritable (see Table 1). 
Mood and Behaviour Disorders 
Rao et al. (25) first described a case of co-occurrence of 
bipolar disorder with psychotic symptoms and Usher 
syndrome. They have suggested that genes implicated in 
the development of Usher syndrome are present on the 
chromosomes 1,8,14, as well as chromosomes 8 and 14 
are implicated in linkage studies of bipolar disorder. 
Praharaj et al. (26) also reported a case of mania 
associated with motor and language retardation in a 
patient affected by USH type II. 
Tamayo et al. (16) reported abnormal mental status in 7 
of 30 patients characterized by borderline mental 
retardation, depression or bipolar affective disorder. 
These disorders were observed in 16.7% of patients 
affected by USH I and in 33.3% with USH II. 
Dammeyer reported that 6 of 26 children had mental and 
behavioral disorders: 1 with schizophrenia and mild 
mental retardation, 2 with atypical autism (1 of them 
with mild and the other with severe mental retardation), 
1 with mild mental retardation and two with conduct 
disorder (9). 
There were very few case studies that described clinical 
manifestations of mood and behavioral disorders in USH. 
Nevertheless, some cases reported the co-occurrence of 
attention deficit hyperactivity disorder, panic attack, 
anxiety, depression, and obsessive rituals with psychotic 
manifestation in USH patients. Moreover, in these 
patients learning disability is often suspected (17,21,23–
24) (See Table 1). 
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Table 1. Summary of the Case Studies Found in the Literature Reporting Psychotic Symptoms in Patients With Usher Syndrome 
USH: Usher syndrome; ADHD: Attention deficit hyperactivity disorder; N.D.: not determinable; FH+: Positive familiar history; PB: parent’s brother;    
*: suspected on the basis of the subject’s behaviour
 USH 
type 
Psychotic manifestations Mood Behaviour Eat/Sleep Mental Status 
Mangotich and 
Misiaszek (1983) 
III (?) Religious delusions, suicidal 
ideation 
Agitation and anxiety  Sleep- N.D. 
Hess-Röver  et al.  
(1999) 
I FH+ (1 PB schizophrenia), 
Visual and auditory 
hallucinations* (probably 
paranoid) 
Anxious and distressed Aggressive and bizarre Sleep - N.D.,  
Intellectual disability 
Poor communication 
McDonald et al. 
(1998) 
II Visual and auditory 
hallucinations 
Religious delusion (paranoid 
schizophrenia) 
   Borderline learning (IQ 74) 
 
Waldeck et al (2001) III FH+ (sister) 
Capgras syndrome 
Paranoid 
Angry, she refuses to 
accept the disease 
Aggressive and self-
injurious  
Sleep- N.D.  
Jumaian and 
Fergusson (2003) 
I Visual and auditory 
hallucinations*  
(Schizophrenia unspecified) 
Depressed, isolation   Anorexia N.D.  
IQ- suspected; 
Wu and Chiu (2006) 
2 cases 
(Siblings) 
II 
 
 
II 
Visual and auditory 
hallucinations*  
 
FH+ (sister) 
Auditory hallucinations and 
persecutory delusion* 
Irritable 
 
 
 
Aggressive  N.D. IQ -suspected; 
Elementary school 
 
N.D. IQ- suspected:  
High school 
Rijavec and Grubic 
(2009) 
III Persecutory delusion, auditory 
hallucinations 
Obsessive rituals, phobia, 
panic attack and anxiety, 
depression 
Opposing behaviour, 
ADHD 
Anorexia N.D.,  
Secondary school 
Domanico et al 
(2013) 
2 cases 
(Siblings) 
II 
 
 
 
II 
FH+ (brother) 
Auditory hallucinations 
 
Visual and auditory 
hallucinations 
persecutory delusion 
(paranoid schizophrenia) 
Irritable,  
isolation 
 
 
Irritable, isolation  
Agitated 
 
 
 
ADHD 
Agitated and 
aggressive 
Panic like-attacks, 
anxiety and obsessive 
Sleep- 
 
 
 
Sleep- 
N.D., normal (Suspected) 
High school; 
 
N.D.; normal (suspected); 
Secondary expert technical 
school; 
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DISCUSSION 
Although a substantial proportion of USH patients suffer 
from psychiatric symptoms, the etiopathogenesis 
remains unclear. Genetic hypothesis, brain damage and 
stress-related theories have been proposed. As reported 
above, two case reports described two siblings with both 
Usher and psychotic manifestations and other two cases 
of eight analysed reported the positive family history of 
schizophrenia (22,24,18,20). Based on these findings, we 
can speculate that there are families with a genetic 
predisposition or susceptibility to develop both USH and 
schizophrenia. Studies of families have been widely used 
to understand the relatives’ contributions of genetic and 
environmental factors upon risk for schizophrenia (27). 
Two genetic loci associated to USH, 11q in type I and 5q 
in type II are also reported in schizophrenia, and it has 
been hypothesized that CNS defects may be among the 
pleiotropic effects of the USH gene (12,22). Although it 
has been hypothesized that one possible explanation for 
relationship between USH and psychotic illness was 
related to the closeness of genetic loci, which are more 
frequently inherited together because of linkage 
disequilibrium. Past studies reported that there was not 
overlap in chromosomal regions for USH and 
schizophrenia, without evidence of the loci on the same 
chromosome (18–20). Mutations in USH2A gene on 
chromosome 1q41 are the most common mutations 
(85% of all cases with USH2), the mutation of USH2A 
gene, 2299delG in exon 13 was found in two siblings 
affected by USH and psychotic manifestations (24, 28). In 
the schizophrenia, various genes are reported as possible 
causative genes, one of these recently discovered is 
DISC1 on chromosome 1q42.2 (27). This gene is on the 
same chromosome and close to the USH2A gene; 
therefore it could be interesting to further investigations. 
A second possible explanation is that Usher syndrome 
consists in a complex syndrome involving CNS diffusely. 
The involvement of CNS implies to consider an 
alternative scenario in which the encephalopathy can 
cause mental disorders. The psychiatric symptoms may 
be related to the diffuse cerebral involvement, this could 
explain why multiple or mixed mental and behavioral 
manifestations, such as hallucinations, delusional 
disorder, ADHD, depression, coexist in the same patient. 
Several authors have proposed that CNS findings may be 
the consequence of the pleiotropic effect of the USH 
genes (14,16). 
The stress-related theory was the first hypothesis 
proposed. This theory is supported by the fact that visual 
or auditory impairment is associated with a higher rate of 
depression, suicidal behavior, psychological stress and 
social handicap. Chronic stress may be related to 
progressive visual loss in a patient who has already 
experienced deafness, and has learned to use mostly the 
vision as the primary sense organ (17, 20). Indeed, 
patients with Usher syndrome and psychotic disorders 
often presented a mood characterized by anxiety, 
irritability, and aggressive behavior as the consequence 
of stress in a person already compromised by dual 
sensory impairments (18–20). 
It is unclear to what degree the risk of psychosis may 
relate to progressive sensory impairment or to 
adaptation of the brain at changes in sensory input. It has 
been suggested that hallucinations in patients with visual 
loss are a consequence of abnormal release of central 
processing, as occurring in Charles Bonnet syndromes 
(17,19–20).). 
 
CONCLUSIONS 
In conclusion, the pathogenesis of psychotic illness is 
probably multifactorial. Multiple genes and 
environmental factors, such as isolation, sensory 
deprivation, anxiety and stress-related disease may be 
involved. Similar to the pathogenesis of schizophrenia 
seems to be a strong genetic predisposition, in which 
stress-inducing factors, especially regarding sensorial 
deprivation, act on this susceptibility to trigger the 
disorder. The pleiotropic effect of the USH genes may 
cause the diffuse involvement of CNS. In addition, the 
diffuse abnormalities of CNS may be contributed to 
atypical or mixed psychiatric symptoms reported in USH 
patients. Further studies are necessary to confirm these 
hypotheses, but the association between USH and 
mental and behavioral disorders cannot be neglected. 
Therefore, an integrated approach with psychological 
support should be considered in these patients, to limit 
the psychological stress and consequently the 
development of mental disturbances. 
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